ARTV Cash-Secured Put Strategy

ARTV (Artiva Biotherapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and various forms of cancer. Its flagship therapeutic candidate, AB-101, is an innovative, ready-to-use (off-the-shelf) NK cell therapy. This treatment is being developed for a broad spectrum of conditions, including autoimmune diseases like lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, systemic lupus erythematosus, and specific anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes such as granulomatosis with polyangiitis/microscopic polyangiitis, in addition to B-cell non-Hodgkin lymphoma. The company's pipeline also includes AB-201, an allogeneic anti-human epidermal growth factor receptor 2 chimeric antigen receptor (CAR)-NK cell candidate, and AB-205, another allogeneic anti-CD5 CAR-NK cell candidate. Established in 2019, Artiva Biotherapeutics is headquartered in San Diego, California.

ARTV (Artiva Biotherapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $563.7M, a beta of 2.18 versus the broader market, a 52-week range of 2.22-14.53, average daily share volume of 527K, a public-listing history dating back to 2024, approximately 106 full-time employees. These structural characteristics shape how ARTV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 2.18 indicates ARTV has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a cash-secured put on ARTV?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

ARTV snapshot

As of August 14, 2026, spot at $11.54, ATM IV 154.20%, expected move 44.21%. The cash-secured put on ARTV below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this cash-secured put structure on ARTV specifically: IV rank is unavailable in the current snapshot, so regime-based timing for ARTV is inferred from ATM IV at 154.20% alone, with a market-implied 1-standard-deviation move of approximately 44.21% (roughly $5.10 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ARTV expiries trade a higher absolute premium for lower per-day decay. Position sizing on ARTV should anchor to the underlying notional of $11.54 per share and to the trader's directional view on ARTV stock.

ARTV cash-secured put setup

The ARTV cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ARTV at $11.54 on that close, the first option leg uses a $10.96 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ARTV chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ARTV shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$10.96N/A

ARTV cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

ARTV cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on ARTV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on ARTV

Cash-secured puts on ARTV earn premium while a trader waits to acquire ARTV stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning ARTV.

ARTV thesis for this cash-secured put

The market-implied 1-standard-deviation range for ARTV extends from approximately $6.44 on the downside to $16.64 on the upside. A ARTV cash-secured put lets a trader earn premium while waiting to acquire ARTV at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. As a Healthcare name, ARTV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ARTV-specific events.

ARTV cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ARTV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ARTV alongside the broader basket even when ARTV-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on ARTV carry tail risk when realized volatility exceeds the implied move; review historical ARTV earnings reactions and macro stress periods before sizing. Always rebuild the position from current ARTV chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on ARTV?
A cash-secured put on ARTV is the cash-secured put strategy applied to ARTV (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With ARTV stock at $11.54 on the most recent close, the strikes shown on this page are snapped to the nearest listed ARTV chain strike and the premiums come straight from that session's bid/ask midpoint.
How are ARTV cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the ARTV cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 154.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ARTV cash-secured put?
The breakeven for the ARTV cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ARTV market-implied 1-standard-deviation expected move in the same options snapshot is approximately 44.21%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on ARTV?
Cash-secured puts on ARTV earn premium while a trader waits to acquire ARTV stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning ARTV.
How does current ARTV implied volatility affect this cash-secured put?
Current ARTV ATM IV is 154.20%; IV rank context is unavailable in the current snapshot.

Related ARTV analysis